• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关异构体 Δ133p53β 的构象稳定性和动态性受 p53 肽和 p53 特异性 DNA 的调节。

Conformational stability and dynamics of the cancer-associated isoform Δ133p53β are modulated by p53 peptides and p53-specific DNA.

机构信息

State Key Laboratory of Surface Physics, Key Laboratory for Computational Physical Sciences-Ministry of Education, Department of Physics, Fudan University, Shanghai, China.

Department of Chemistry, Institute of Biomedical Sciences, Fudan University, Shanghai, China.

出版信息

FASEB J. 2019 Mar;33(3):4225-4235. doi: 10.1096/fj.201801973R. Epub 2018 Dec 12.

DOI:10.1096/fj.201801973R
PMID:30540922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6404584/
Abstract

p53 is a tumor suppressor protein that maintains genome stability, but its Δ133p53β and Δ160p53β isoforms promote breast cancer cell invasion. The sequence truncations in the p53 core domain raise key questions related to their physicochemical properties, including structural stabilities, interaction mechanisms, and DNA-binding abilities. Herein, we investigated the conformational dynamics of Δ133p53β and Δ160p53β with and without binding to p53-specific DNA by using molecular dynamics simulations. We observed that the core domains of the 2 truncated isoforms are much less stable than wild-type (wt) p53β, and the increased solvent exposure of their aggregation-triggering segment indicates their higher aggregation propensities than wt p53. We also found that Δ133p53β stability is modulable by peptide or DNA interactions. Adding a p53 peptide (derived from truncated p53 sequence 107-129) may help stabilize Δ133p53. Most importantly, our simulations of p53 isomer-DNA complexes indicate that Δ133p53β dimer, but not Δ160p53β dimer, could form a stable complex with p53-specific DNA, which is consistent with recent experiments. This study provides physicochemical insight into Δ133p53β, Δ133p53β-DNA complexes, Δ133p53β's pathologic mechanism, and peptide-based inhibitor design against p53-related cancers.-Lei, J., Qi, R., Tang, Y., Wang, W., Wei, G., Nussinov, R., Ma, B. Conformational stability and dynamics of the cancer-associated isoform Δ133p53β are modulated by p53 peptides and p53-specific DNA.

摘要

p53 是一种肿瘤抑制蛋白,可维持基因组稳定性,但它的 Δ133p53β 和 Δ160p53β 异构体可促进乳腺癌细胞的侵袭。p53 核心结构域中的序列缺失提出了与物理化学性质相关的关键问题,包括结构稳定性、相互作用机制和 DNA 结合能力。在此,我们通过分子动力学模拟研究了与 p53 特异性 DNA 结合或不结合时 Δ133p53β 和 Δ160p53β 的构象动力学。我们观察到,2 种截断异构体的核心结构域的稳定性远低于野生型(wt)p53β,其聚集触发片段的溶剂暴露增加表明它们的聚集倾向高于 wt p53。我们还发现 Δ133p53β 的稳定性可通过肽或 DNA 相互作用进行调节。添加 p53 肽(源自截断 p53 序列 107-129)可能有助于稳定 Δ133p53。最重要的是,我们对 p53 异构体-DNA 复合物的模拟表明,Δ133p53β 二聚体,但不是 Δ160p53β 二聚体,可与 p53 特异性 DNA 形成稳定的复合物,这与最近的实验结果一致。该研究为 Δ133p53β、Δ133p53β-DNA 复合物、Δ133p53β 的病理机制以及针对 p53 相关癌症的基于肽的抑制剂设计提供了物理化学见解。-雷静,齐锐,唐颖,王炜,魏刚,努斯林诺夫,马炳,癌症相关异构体 Δ133p53β 的构象稳定性和动力学受 p53 肽和 p53 特异性 DNA 的调节。

相似文献

1
Conformational stability and dynamics of the cancer-associated isoform Δ133p53β are modulated by p53 peptides and p53-specific DNA.癌症相关异构体 Δ133p53β 的构象稳定性和动态性受 p53 肽和 p53 特异性 DNA 的调节。
FASEB J. 2019 Mar;33(3):4225-4235. doi: 10.1096/fj.201801973R. Epub 2018 Dec 12.
2
drives invasion through expression of its Δ133p53β variant.通过其Δ133p53β变体的表达驱动侵袭。
Elife. 2016 Sep 15;5:e14734. doi: 10.7554/eLife.14734.
3
Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells.Δ133p53β 异构体的促侵袭活性通过癌细胞中的聚集依赖性机制进行调节。
Nat Commun. 2021 Sep 15;12(1):5463. doi: 10.1038/s41467-021-25550-2.
4
Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.在胶质母细胞瘤中,TP53 异构体 Δ133p53β 的升高:一种替代突变型 p53 促进肿瘤发展的途径。
J Pathol. 2018 Sep;246(1):77-88. doi: 10.1002/path.5111. Epub 2018 Jul 31.
5
Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis.活化的 CD90/Thy-1 成纤维细胞共同表达 Δ133p53β 异构体,与高度炎症性类风湿关节炎有关。
Arthritis Res Ther. 2023 Apr 15;25(1):62. doi: 10.1186/s13075-023-03040-8.
6
The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.p53 异构体 Δ133p53α 促进血管生成和肿瘤进展。
Oncogene. 2013 Apr 25;32(17):2150-60. doi: 10.1038/onc.2012.242. Epub 2012 Jun 25.
7
Functional characterization of p53beta and p53gamma, two isoforms of the tumor suppressor p53.肿瘤抑制因子p53的两种异构体p53β和p53γ的功能特性
Cell Cycle. 2009 Apr 15;8(8):1238-48. doi: 10.4161/cc.8.8.8251. Epub 2009 Apr 23.
8
Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.细胞质 p53β 异构体与乳腺癌无病生存不良相关。
Int J Mol Sci. 2022 Jun 15;23(12):6670. doi: 10.3390/ijms23126670.
9
The p53 isoform Δ133p53β promotes cancer stem cell potential.Δ133p53β 异构体促进癌症干细胞潜能。
Stem Cell Reports. 2015 Apr 14;4(4):531-40. doi: 10.1016/j.stemcr.2015.02.001. Epub 2015 Mar 5.
10
Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis.Δ133p53β 异构体表达增加增强脑转移。
Int J Mol Sci. 2023 Jan 9;24(2):1267. doi: 10.3390/ijms24021267.

引用本文的文献

1
p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partners.p53 异构体具有较高的聚集倾向,与伴侣蛋白相互作用,且缺乏与 p53 相互作用伙伴的结合。
Elife. 2025 Sep 10;13:RP103537. doi: 10.7554/eLife.103537.
2
Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation.肿瘤抑制蛋白p53的Δ133p53α和Δ160p53α亚型主要通过共聚集发挥显性负效应。
Elife. 2025 Jul 21;14:RP106469. doi: 10.7554/eLife.106469.
3
Mechanistic Insights into the Mechanism of Allosteric Inhibition of Ubiquitin-Specific Protease 7 (USP7).泛素特异性蛋白酶7(USP7)变构抑制机制的机理洞察
Biomolecules. 2025 May 22;15(6):749. doi: 10.3390/biom15060749.
4
Recent Research on Role of p53 Family in Small-Cell Lung Cancer.p53家族在小细胞肺癌中作用的最新研究
Cancers (Basel). 2025 Mar 26;17(7):1110. doi: 10.3390/cancers17071110.
5
Human Disabled-2 regulates thromboxane A signaling for efficient hemostasis in thrombocytopenia.人类Disabled-2 调节血栓素 A 信号转导以实现血小板减少症中的有效止血。
Nat Commun. 2024 Nov 13;15(1):9816. doi: 10.1038/s41467-024-54093-5.
6
Multiscale simulations reveal the driving forces of p53C phase separation accelerated by oncogenic mutations.多尺度模拟揭示了致癌突变加速p53C相分离的驱动力。
Chem Sci. 2024 Jul 15;15(32):12806-12818. doi: 10.1039/d4sc03645j. eCollection 2024 Aug 14.
7
Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.p53 异构体的规范和非规范功能:增强肿瘤发展和治疗耐药性的复杂性。
Cell Death Dis. 2024 Jun 12;15(6):412. doi: 10.1038/s41419-024-06783-7.
8
It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort.并非一切都与α有关:在一个回顾性黑色素瘤队列中,p53β变体的高表达与较低的生存概率相关。
Cancer Cell Int. 2023 Oct 4;23(1):228. doi: 10.1186/s12935-023-03083-6.
9
Insights into Allosteric Mechanisms of the Lung-Enriched p53 Mutants V157F and R158L.肺组织特异性 p53 突变体 V157F 和 R158L 的别构机制研究进展。
Int J Mol Sci. 2022 Sep 3;23(17):10100. doi: 10.3390/ijms231710100.
10
p53 Isoforms as Cancer Biomarkers and Therapeutic Targets.p53 异构体作为癌症生物标志物和治疗靶点。
Cancers (Basel). 2022 Jun 27;14(13):3145. doi: 10.3390/cancers14133145.

本文引用的文献

1
p73 coordinates with Δ133p53 to promote DNA double-strand break repair.p73 与 Δ133p53 协调以促进 DNA 双链断裂修复。
Cell Death Differ. 2018 Jun;25(6):1063-1079. doi: 10.1038/s41418-018-0085-8. Epub 2018 Mar 6.
2
New therapeutic strategies to treat human cancers expressing mutant p53 proteins.治疗表达突变型 p53 蛋白的人类癌症的新治疗策略。
J Exp Clin Cancer Res. 2018 Feb 15;37(1):30. doi: 10.1186/s13046-018-0705-7.
3
A functional interplay between Δ133p53 and ΔNp63 in promoting glycolytic metabolism to fuel cancer cell proliferation.Δ133p53 和 ΔNp63 之间的功能相互作用促进糖酵解代谢以促进癌细胞增殖。
Oncogene. 2018 Apr;37(16):2150-2164. doi: 10.1038/s41388-017-0117-8. Epub 2018 Jan 26.
4
Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer.靶向突变 p53 的朊病毒样聚集以对抗癌症。
Acc Chem Res. 2018 Jan 16;51(1):181-190. doi: 10.1021/acs.accounts.7b00473. Epub 2017 Dec 20.
5
Interplay between PTB and miR-1285 at the p53 3'UTR modulates the levels of p53 and its isoform Δ40p53α.PTB与miR-1285在p53 3'非翻译区的相互作用调节p53及其异构体Δ40p53α的水平。
Nucleic Acids Res. 2017 Sep 29;45(17):10206-10217. doi: 10.1093/nar/gkx630.
6
Post-translational regulation of p53 function through 20S proteasome-mediated cleavage.通过 20S 蛋白酶体介导的切割对 p53 功能的翻译后调控。
Cell Death Differ. 2017 Dec;24(12):2187-2198. doi: 10.1038/cdd.2017.139. Epub 2017 Sep 8.
7
The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner.p53 异构体 delta133p53β 以 RhoB 依赖的方式调节癌细胞凋亡。
PLoS One. 2017 Feb 17;12(2):e0172125. doi: 10.1371/journal.pone.0172125. eCollection 2017.
8
Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis.p53基因中的癌症特异性突变可诱导Δ160p53的翻译,从而促进肿瘤发生。
EMBO Rep. 2016 Nov;17(11):1542-1551. doi: 10.15252/embr.201541956. Epub 2016 Oct 4.
9
drives invasion through expression of its Δ133p53β variant.通过其Δ133p53β变体的表达驱动侵袭。
Elife. 2016 Sep 15;5:e14734. doi: 10.7554/eLife.14734.
10
Role of p53 isoforms and aggregations in cancer.p53 异构体及聚集体在癌症中的作用。
Medicine (Baltimore). 2016 Jun;95(26):e3993. doi: 10.1097/MD.0000000000003993.